Data Analysis
Reviewed and published by trentmaziarz, July 11, 2026. Discovered and drafted by our automated research pipeline.
Beth Israel Lahey Health announced plans to use AI-enhanced tools to match patients to clinical trials as part of a new high-performance computing infrastructure funded by a Dell Technologies grant. The initiative was announced in May 2026 and is not yet confirmed as fully deployed.
Details
Building on Beth Israel Deaconess Medical Center's existing i2b2 (Informatics for Integrating Biology and the Bedside) patient data system, the planned AI tools are intended to screen and match eligible patients to open clinical trials at scale, reducing enrollment delays. The new HPC cluster, enabled by a Dell Technologies grant, provides the GPU computing power needed to run large-scale AI and predictive modeling workloads. As of the announcement, this is a stated priority for the new infrastructure rather than a confirmed operational deployment.
Products affected
HPC cluster (Dell Technologies grant)i2b2 system
Sources & Evidence
Other practices by Beth Israel Lahey Health
Data AnalysisBeth Israel Lahey Health uses an internally developed AI model that predicts whether a patient is likely to miss a scheduled appointment. The tool is used by BILH's IT department to support scheduling decisions and patient outreach.ProductivityBeth Israel Lahey Health deployed Heidi, an ambient AI scribe tool, system-wide to all of its more than 6,000 physicians across 14 hospitals and 175 primary care practices. The rollout followed a six-month pilot with 1,000 providers that showed strong satisfaction and time savings.ProductivityBeth Israel Lahey Health integrated an AI-powered internal chatbot called ChatPPGD that lets clinical staff search more than 3,800 care guidance documents by asking questions in plain language. The tool is used internally by attending staff and fields over 800 queries per week.
Have evidence about Beth Israel Lahey Health's AI practices? Submit a report.
Report a Sighting →